GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ATAI Life Sciences NV (FRA:9VC) » Definitions » Marketable Securities

ATAI Life Sciences NV (FRA:9VC) Marketable Securities : €42.81 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is ATAI Life Sciences NV Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. ATAI Life Sciences NV's Marketable Securities for the quarter that ended in Dec. 2024 was €42.81 Mil.

ATAI Life Sciences NV's annual Marketable Securities increased from Dec. 2022 (€77.88 Mil) to Dec. 2023 (€123.08 Mil) but then declined from Dec. 2023 (€123.08 Mil) to Dec. 2024 (€42.81 Mil).


ATAI Life Sciences NV Marketable Securities Historical Data

The historical data trend for ATAI Life Sciences NV's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ATAI Life Sciences NV Marketable Securities Chart

ATAI Life Sciences NV Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Marketable Securities
Get a 7-Day Free Trial - - 77.88 123.08 42.81

ATAI Life Sciences NV Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 123.08 80.39 64.11 50.42 42.81

ATAI Life Sciences NV Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


ATAI Life Sciences NV  (FRA:9VC) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".


ATAI Life Sciences NV Marketable Securities Related Terms

Thank you for viewing the detailed overview of ATAI Life Sciences NV's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


ATAI Life Sciences NV Business Description

Traded in Other Exchanges
Address
Wallstrasse 16, Berlin, BB, DEU, 10179
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.

ATAI Life Sciences NV Headlines

No Headlines